Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Remark

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Immunity|April 21, 2016
Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF InhibitionHélène Salmon, Juliana Idoyaga, Adeeb Rahman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2013
Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor originRomain Remark, Marco Alifano, Isabelle Cremer, et al.
Oncotarget|February 2, 2017
MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapySimon Laban, Gregor Giebel, Niklas Klümper, et al.
Cell|June 4, 2019
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor ImmunityLaurent Gauthier, Ariane Morel, Nadia Anceriz, et al.
Nature|July 30, 2020
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axisJulien Carvelli, Olivier Demaria, Frédéric Vély, et al.
The Journal of Experimental Medicine|December 22, 2017
RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesionsBrandon Hogstad, Marie-Luise Berres, Rikhia Chakraborty, et al.
Open Research Europe|August 30, 2023
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor controlMathieu Bléry, Manel Mrabet-Kraiem, Ariane Morel, et al.
Nature Medicine|October 9, 2019
Single-cell immune landscape of human atherosclerotic plaquesDawn M Fernandez, Adeeb H Rahman, Nicolas F Fernandez, et al.
Cell|December 4, 2018
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK CellsPascale André, Caroline Denis, Caroline Soulas, et al.
Cell|May 6, 2017
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell AnalysesYonit Lavin, Soma Kobayashi, Andrew Leader, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Immunity|April 21, 2016
Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF InhibitionHélène Salmon, Juliana Idoyaga, Adeeb Rahman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2013
Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor originRomain Remark, Marco Alifano, Isabelle Cremer, et al.
Oncotarget|February 2, 2017
MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapySimon Laban, Gregor Giebel, Niklas Klümper, et al.
Cell|June 4, 2019
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor ImmunityLaurent Gauthier, Ariane Morel, Nadia Anceriz, et al.
Nature|July 30, 2020
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axisJulien Carvelli, Olivier Demaria, Frédéric Vély, et al.
The Journal of Experimental Medicine|December 22, 2017
RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesionsBrandon Hogstad, Marie-Luise Berres, Rikhia Chakraborty, et al.
Open Research Europe|August 30, 2023
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor controlMathieu Bléry, Manel Mrabet-Kraiem, Ariane Morel, et al.
Nature Medicine|October 9, 2019
Single-cell immune landscape of human atherosclerotic plaquesDawn M Fernandez, Adeeb H Rahman, Nicolas F Fernandez, et al.
Cell|December 4, 2018
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK CellsPascale André, Caroline Denis, Caroline Soulas, et al.
Cell|May 6, 2017
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell AnalysesYonit Lavin, Soma Kobayashi, Andrew Leader, et al.
Pageof 4